Journal of Lipid Research, Vol 35, 1552-1560, Copyright © 1994 by Lipid Research, Inc.

ARTICLES

A novel missense mutation in the C-terminal domain of lipoprotein lipase (Glu410-->Val) leads to enzyme inactivation and familial chylomicronemia

L Previato, O Guardamagna, KA Dugi, R Ronan, GD Talley, S Santamarina-Fojo and HB Brewer Jr
Molecular Disease Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892.

Lipoprotein lipase (LPL) is a complex enzyme consisting of multiple functional domains essential for the initial hydrolysis of triglycerides present in plasma lipoproteins. Previous studies have localized the catalytic domain of LPL, responsible for the hydrolytic function of the enzyme, to the N-terminus whereas the C-terminal end may play a role in lipid and heparin binding. To date, most described missense mutations resulting in a nonfunctional LPL have been located in the N-terminal region of the enzyme. In this manuscript we describe the defect in the LPL gene of a patient with triglycerides ranging from normal to 12,000 mg/dl, low LPL mass, and no LPL activity in post- heparin plasma. Sequencing of patient PCR-amplified DNA identified two separate mutations in the C-terminal domain of LPL: an A-->T transversion at nucleotide 1484 resulting in a Glu410-->Val substitution and a C-->G mutation at position 1595 that introduces a premature stop codon at position 447. Digestion with MaeIII and MnII established that the patient is a true homozygote for both mutations. In order to investigate the functional significance of these defects, mutant enzymes containing either the Val410 or the Ter447 mutations as well as both Val410 and Ter447, were expressed in vitro. Compared to the wild-type enzyme, LPL447 demonstrated a moderate reduction of specific activity using triolein (70% of normal) and tributyrin (74% of normal) substrates, while LPL410 had a significant (11% and 23% of normal) reduction of the normal lipase and esterase specific activities, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				T. Ebara, T. Murase, and M. Okubo Is LPL Deficiency Atherogenic? Circ. Res., June 6, 2008; 102(11): e118 - e118. [Full Text] [PDF]

				B. Herbeth, S. Gueguen, P. Leroy, G. Siest, and S. Visvikis-Siest The Lipoprotein Lipase Serine 447 Stop Polymorphism Is Associated With Altered Serum Carotenoid Concentrations in the Stanislas Family Study J. Am. Coll. Nutr., December 1, 2007; 26(6): 655 - 662. [Abstract] [Full Text] [PDF]

				J. Rip, M. C. Nierman, C. J. Ross, J. W. Jukema, M. R. Hayden, J. J.P. Kastelein, E. S.G. Stroes, and J. A. Kuivenhoven Lipoprotein Lipase S447X: A Naturally Occurring Gain-of-Function Mutation Arterioscler. Thromb. Vasc. Biol., June 1, 2006; 26(6): 1236 - 1245. [Abstract] [Full Text] [PDF]

				C. J.D. Ross, G. Liu, J. A. Kuivenhoven, J. Twisk, J. Rip, W. van Dop, K. J.D. Ashbourne Excoffon, S. M.E. Lewis, J. J. Kastelein, and M. R. Hayden Complete Rescue of Lipoprotein Lipase-Deficient Mice by Somatic Gene Transfer of the Naturally Occurring LPLS447X Beneficial Mutation Arterioscler. Thromb. Vasc. Biol., October 1, 2005; 25(10): 2143 - 2150. [Abstract] [Full Text] [PDF]

				S. H. McGladdery and J. J. Frohlich Lipoprotein lipase and apoE polymorphisms: relationship to hypertriglyceridemia during pregnancy J. Lipid Res., November 1, 2001; 42(11): 1905 - 1912. [Abstract] [Full Text] [PDF]

				T. Keiper, J. G. Schneider, and K. A. Dugi Novel site in lipoprotein lipase (LPL415;-438) essential for substrate interaction and dimer stability J. Lipid Res., August 1, 2001; 42(8): 1180 - 1186. [Abstract] [Full Text] [PDF]

				H. E. Henderson, J. J. P. Kastelein, A. H. Zwinderman, E. Gagné, J. W. Jukema, P. W. A. Reymer, B. E. Groenemeyer, K. I. Lie, A. V. G. Bruschke, M. R. Hayden, et al. Lipoprotein lipase activity is decreased in a large cohort of patients with coronary artery disease and is associated with changes in lipids and lipoproteins J. Lipid Res., April 1, 1999; 40(4): 735 - 743. [Abstract] [Full Text]

				S.-F. Chang, B. Reich, J. D. Brunzell, and H. Will Detailed characterization of the binding site of the lipoprotein lipase-specific monoclonal antibody 5D2 J. Lipid Res., December 1, 1998; 39(12): 2350 - 2359. [Abstract] [Full Text]

				R. Buscà, M. Martínez, E. Vilella, J. Peinado, J. L. Gelpi, S. Deeb, J. Auwerx, M. Reina, and S. Vilaró The carboxy-terminal region of human lipoprotein lipase is necessary for its exit from the endoplasmic reticulum J. Lipid Res., April 1, 1998; 39(4): 821 - 833. [Abstract] [Full Text]

				S. E. Humphries, V. Nicaud, J. Margalef, L. Tiret, P. J. Talmud, and f. t. EARS Lipoprotein Lipase Gene Variation Is Associated With a Paternal History of Premature Coronary Artery Disease and Fasting and Postprandial Plasma Triglycerides : The European Atherosclerosis Research Study (EARS) Arterioscler. Thromb. Vasc. Biol., April 1, 1998; 18(4): 526 - 534. [Abstract] [Full Text] [PDF]

				J. A. Thorn, E. W. A. Needham, R. K. Mattu, J. Stocks, and D. J. Galton The Ser447–Ter mutation of the lipoprotein lipase gene relates to variability of serum lipid and lipoprotein levels in monozygotic twins1 J. Lipid Res., February 1, 1998; 39(2): 437 - 441. [Abstract] [Full Text]

				J. A. Kuivenhoven, B. E. Groenemeyer, J. M. A. Boer, P. W. A. Reymer, R. Berghuis, T. Bruin, H. Jansen, J. C. Seidell, and J. J. P. Kastelein Ser447stop Mutation in Lipoprotein Lipase Is Associated With Elevated HDL Cholesterol Levels in Normolipidemic Males Arterioscler. Thromb. Vasc. Biol., March 1, 1997; 17(3): 595 - 599. [Abstract] [Full Text]